|
|
Other links at Articles > Cardiology |
| 1. |
FDA Safety Changes: DepoDur, Neoral, Lexiva
|
|
|
The FDA has approved safety labeling revisions for morphine sulfate extended-release liposome injection, cyclosporine capsules and oral solution, and fosamprenavir calcium tablets and oral suspension. Medscape Medical News
|
| 2. |
EUROASPIRE III: Not Enough Being Done in the Treatment of High-Risk Primary-Prevention Patients
|
|
|
Investigators told the audience that almost 85% of patients wanted to know their risk of heart disease, but very few knew their real risk, assuming they were as healthy as men and women their own age. Also, more than 80% of those participating in the survey were not provided with a professional lifestyle and risk-factor management program, despite evidence that such programs are effective. Heartwire
|
|
|
